With new mis­sion in psy­chi­a­try, Au­to­bahn rais­es $100M to help back Phase 2 work

Au­to­bahn Ther­a­peu­tics’ jour­ney through the clin­ic has been any­thing but speedy.

The ARCH-backed start­up launched out of stealth more than four years ago in June …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER